It’s A Great Day To Buy Second Sight Medical Products, Inc. (EYES) on the rise

It’s A Great Day To Buy Second Sight Medical Products, Inc. (EYES) on the rise

It’s A Great Day To Buy Second Sight Medical Products, Inc. (EYES) on the rise

Second Sight Medical Products, Inc. (NASDAQ:EYES) is expected to announce second quarter financial results after market close (confirmed) on August 08, 2017. The company added about 0.8% percent in value since last earnings when it was at $1.27. Based on the most relevant historical data, there is a 88 percent probability for share price to go down following the next earnings report. Looking further into earnings reaction history, the stock had moved down 8 times out of last 9 quarters. It has topped earnings-per-share estimates 10% of the time in its last 12 earnings reports. It missed earnings on 2 occasions, and it has met expectations 2 time.

Second Sight Medical Products, Inc. (NASDAQ:EYES) Earnings Reaction History

Overall, the average earnings surprise was -33.45 percent over the past four quarters. It posted earnings per share at $-0.16 which missed the consensus $-0.14 projection (Negative surprise of -14.30%). Revenue came in at $1.01M versus consensus estimate of $1.32M. The stock dropped -6.30% percent the day following the earnings was released, and on 7th day price change was -6.30% percent.

On March 09, 2017, it posted earnings per share at $-0.24 versus the consensus estimate of $-0.17 (Negative surprise of -41.20%). Revenue of $0.71M was below the $1.76M analysts had expected. The stock dropped -7.10% the day following the earnings was released, and on 7th day price change was -21.94%.

On November 02, 2016, it posted earnings per share at $-0.2, missed the consensus estimate of $-0.16 (Negative surprise of -25.00%). Revenue for the quarter was $1.18M while analysts had expected revenues to come in at $2.36M. The stock fell -13.91% the day following the earnings was released, and on 7th day price change was -4.61%.

On July 28, 2016, it posted earnings per share at $-0.23 compared with the consensus estimate of $-0.15 (Negative surprise of -53.30%). That came on revenues of $1.04M for the quarter. Analysts had expected $1.38M in revenue.

Second Sight Medical Products, Inc. (NASDAQ:EYES) Earnings Expectations

In front of Q3 earnings release, Wall Street is expecting earnings per share of $-0.15. The analysts’ current consensus range is $-0.15-$-0.15 for EPS. The market consensus range for revenue is $1.43M-$1.43M, with an average of $1.43M.

Second Sight Medical Products, Inc. (NASDAQ:EYES) last closed at $1.27, sending the company’s market cap around $72.67M. The consensus 12-month price target from brokerage firms covering the stock is $5.00 . The share price has declined -72.09% from its best level in 52 weeks and advanced -35.53% this year. It recently traded in a range of $1.25-$1.46 at a volume of 1,802,863 shares. The stock ended last trading session with the price nearly -3.05% lower for the last 5 trading days, rebounding 19.81% from its 52-week low.

 

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.